Related Experiment Video
Updated: Aug 22, 2026
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Microarray evaluation of EP4 receptor-mediated prostaglandin E2 suppression of 3T3-L1 adipocyte differentiation
Yukihiko Sugimoto1, Hiroaki Tsuboi, Yasushi Okuno
1Department of Physiological Chemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Sakyo-ku, Kyoto 606-8501, Japan.
Abstract:
Prostaglandin E(2) (PGE(2)) has been shown to negatively regulate adipogenesis. To explore to what extent PGE(2) inhibits the differentiation of cells to adipocytes and to examine whether its effect could be due to EP4 receptor signaling, we used microarrays to analyze the gene expression profiles of 3T3-L1 cells exposed to a differentiation cocktail supplemented with PGE(2), AE1-329 (an EP4 agonist), or vehicle. The differentiation-associated responses in genes such as adipocytokines and enzymes related to lipid metabolism were largely weakened upon PGE(2) treatment. In particular, the expression of peroxisome proliferator activated receptor-gamma and CCAAT/enhancer binding protein-alpha, genes playing a central role in adipogenesis, was greatly suppressed. PGE(2) appears to be ineffective to a subclass of insulin target genes such as hexokinase 2 and phosphofructokinase. Similar responses were produced in the differentiation-associated genes upon AE1-329 treatment. These results suggest that PGE(2) inhibits a crucial step of the adipocyte differentiation process by acting on the EP4 receptor in 3T3-L1 cells.
Insights
Prostaglandin E(2) (PGE(2)) significantly inhibits adipocyte differentiation by suppressing key regulatory genes. This effect is mediated through the EP4 receptor, impacting lipid metabolism and adipokine signaling in 3T3-L1 cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Prostaglandin E(2) (PGE(2)) is known to inhibit adipogenesis.
- The specific mechanisms and receptor involvement in PGE(2)-mediated inhibition of adipocyte differentiation require further elucidation.
Purpose of the Study:
- To investigate the extent to which PGE(2) inhibits adipocyte differentiation.
- To determine if PGE(2) exerts its inhibitory effects via EP4 receptor signaling.
Main Methods:
- Gene expression profiling using microarrays.
- Treatment of 3T3-L1 cells with PGE(2), an EP4 agonist (AE1-329), or vehicle during differentiation.
Main Results:
- PGE(2) treatment significantly weakened differentiation-associated gene responses, including adipocytokines and lipid metabolism enzymes.
- Expression of key adipogenic transcription factors, peroxisome proliferator activated receptor-gamma and CCAAT/enhancer binding protein-alpha, was markedly suppressed by PGE(2).
- AE1-329 treatment mimicked the effects of PGE(2) on differentiation-associated genes, suggesting EP4 receptor mediation.
Conclusions:
- PGE(2) inhibits a critical step in the adipocyte differentiation process in 3T3-L1 cells.
- The inhibitory action of PGE(2) on adipogenesis is mediated through the EP4 receptor.
